285 filings
Page 10 of 15
6-K
kgmtcxi1 st
30 Apr 20
Imv Announces Proposed $22.3 Million Private Placement
1:29pm
6-K
vtolnjt eyyzq
22 Apr 20
IMV to participate inAdelaide Capital’s Virtual COVID & Healthcare Mini Conference
10:43am
6-K
2z7ax1
7 Apr 20
Report of Foreign Private Issuer for the Month of April, 2020
3:58pm
6-K
c4zod0o
30 Mar 20
IMV Inc. Announces Fourth Quarter and Full Year 2019 Financial and Operational Results
5:17pm
40-F
86cu2ml 8b9emfrxhjp
30 Mar 20
Annual report (Canada)
5:11pm
6-K
38t5i 4tpgzef3zt
30 Mar 20
IMV Inc. Provides Updates on the Development of DPX-COVID-19 Vaccine and Ongoing Business and Clinical Operations
9:27am
6-K
yw7w46nryq
25 Mar 20
Report of Foreign Private Issuer for the Month of March, 2020
10:13am
6-K
4gwm197n h64yzf3
18 Mar 20
IMV Inc. Launches Plans to Advance Clinical Development of a Vaccine Candidate Against COVID-19
9:00am
6-K
bng7xaa05pc37z
18 Mar 20
Current report (foreign)
8:30am
SUPPL
bfo1rluws d0m
18 Mar 20
Supplemental materials (foreign)
8:08am
6-K
2u6e3
18 Mar 20
Material Change Report
6:48am
6-K
pqqgw2ne7 eay2
25 Feb 20
IMV Inc. Announces Breakthrough Data from DeCidE1, its Ongoing Phase 2 Study of DPX-Survivac in Patients with Advanced Recurrent Ovarian Cancer
1:22pm
6-K
w1ga81ryc6c408d5otms
20 Feb 20
Report of Foreign Private Issuer for the Month of February, 2020
4:13pm
6-K
8kc7j3i950neo
18 Feb 20
IMV Announces Board Retirement
10:31am
6-K
x2hxva18 s0ktm6owg
4 Feb 20
Clinical Translational Data Supporting DPX-Survivac Mechanism of Action to be Presented at 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
12:31pm
6-K
66vjkj2a32054v
31 Jan 20
IMV to Present at 2020 BIO CEO & Investor Conference
9:21am
6-K
w7bkz2ku7b7aqo u46
24 Jan 20
IMV to Host Key Opinion Leader Symposium on Role of Survivin in Cancer Biology and Potential of DPX-Survivac
10:54am
6-K
ha22a ui1c7e23oknv4
9 Dec 19
Report of Foreign Private Issuer for the Month of December, 2019
11:57am
6-K
xv63e5tkoi 9ckmoqoe
27 Nov 19
IMV to Participate at Two Upcoming Investor Conferences
11:57am
6-K
5whb7d9434dxfvx r4p
8 Nov 19
IMV Inc. Announces Third Quarter 2019 Financial Results and Provides Corporate Update
9:38am